Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,212 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sharing primary percutaneous coronary intervention care: first experiences with South Limburg ST-elevation myocardial infarction network.
Lux A, Vainer J, Theunissen RALJ, Veenstra LF, Kasperski I, Gho BCG, Stein M, Ilhan M, Ruiters AW, Winkler PJC, van Beurden A, Dohmen W, Rasoul S, van 't Hof AWJ; South Limburg Interventional Cardiology Group, the Netherlands. Lux A, et al. Among authors: stein m. Neth Heart J. 2021 Jun;29(6):348-353. doi: 10.1007/s12471-021-01541-2. Epub 2021 Feb 3. Neth Heart J. 2021. PMID: 33534114 Free PMC article.
Long-term outcome after deferred revascularization due to negative fractional flow reserve in intermediate coronary lesions.
Weerts J, Pustjens T, Amin E, Ilhan M, Veenstra LF, Theunissen RALJ, Vainer J, Stein M, Ruiters LAW, Gho BCG, Van't Hof AWJ, Rasoul S. Weerts J, et al. Among authors: stein m. Catheter Cardiovasc Interv. 2021 Feb 1;97(2):247-256. doi: 10.1002/ccd.28753. Epub 2020 Jan 30. Catheter Cardiovasc Interv. 2021. PMID: 31999077 Free PMC article.
Impact of opioids on P2Y12 receptor inhibition in patients with ST-elevation myocardial infarction who are pre-treated with crushed ticagrelor: Opioids aNd crushed Ticagrelor In Myocardial infarction Evaluation (ON-TIME 3) trial.
Tavenier AH, Hermanides RS, Ottervanger JP, Tolsma R, van Beurden A, Slingerland RJ, Ter Horst PGJ, Gosselink ATM, Dambrink JE, van Leeuwen MAH, Roolvink V, Kedhi E, Klungel OH, Belitser SV, Angiolillo DJ, Pustjens T, Rasoul S, Gho B, Stein M, Ruiters L, van 't Hof AWJ. Tavenier AH, et al. Among authors: stein m. Eur Heart J Cardiovasc Pharmacother. 2022 Jan 5;8(1):4-12. doi: 10.1093/ehjcvp/pvaa095. Eur Heart J Cardiovasc Pharmacother. 2022. PMID: 32730628 Free PMC article. Clinical Trial.
Direct comparison of predictive performance of PRECISE-DAPT versus PARIS versus CREDO-Kyoto: a subanalysis of the ReCre8 trial.
Rozemeijer R, van Bezouwen WP, van Hemert ND, Damen JA, Koudstaal S, Stein M, Leenders GE, Timmers L, Kraaijeveld AO, Roes K, Agostoni P, Doevendans PA, Stella PR, Voskuil M. Rozemeijer R, et al. Among authors: stein m. Neth Heart J. 2021 Apr;29(4):201-214. doi: 10.1007/s12471-020-01486-y. Neth Heart J. 2021. PMID: 32955703 Free PMC article.
Prevalence of a History of Metabolic or Hypertensive Pregnancy Disorder in Patients With Myocardial Infarction and Non-obstructive Coronary Arteries: An Observational Cohort Study.
Pustjens TFS, Vranken NPA, Jansen G, Winkler PJC, Stein M, Hoebers L, Kietselaer B, Spaanderman MEA, Rasoul S, Ghossein-Doha C, van 't Hof AWJ. Pustjens TFS, et al. Among authors: stein m. Front Cardiovasc Med. 2022 Jul 15;9:932799. doi: 10.3389/fcvm.2022.932799. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35911523 Free PMC article.
Polymer-based or Polymer-free Stents in Patients at High Bleeding Risk.
Windecker S, Latib A, Kedhi E, Kirtane AJ, Kandzari DE, Mehran R, Price MJ, Abizaid A, Simon DI, Worthley SG, Zaman A, Hudec M, Poliacikova P, Abdul Ghapar AKB, Selvaraj K, Petrov I, Mylotte D, Pinar E, Moreno R, Fabbiocchi F, Pasupati S, Kim HS, Aminian A, Tie C, Wlodarczak A, Hur SH, Marx SO, Jankovic I, Brar S, Bousquette L, Liu M, Stone GW; ONYX ONE Investigators. Windecker S, et al. N Engl J Med. 2020 Mar 26;382(13):1208-1218. doi: 10.1056/NEJMoa1910021. Epub 2020 Feb 12. N Engl J Med. 2020. PMID: 32050061 Free article. Clinical Trial.
High bleeding risk in patients undergoing percutaneous coronary intervention with drug-eluting stent implantation: ReCre8 subanalysis.
van Hemert ND, Stella PR, Rozemeijer R, Stein M, Frambach P, Kraaijeveld AO, Rittersma SZ, Meijs TA, Leenders GEH, van der Harst P, Agostoni P, Voskuil M; ReCre8 Study Investigators. van Hemert ND, et al. Among authors: stein m. Am Heart J Plus. 2022 Nov 9;24:100227. doi: 10.1016/j.ahjo.2022.100227. eCollection 2022 Dec. Am Heart J Plus. 2022. PMID: 38560639 Free PMC article.
Rationale and design of amphilimus sirolimus-eluting stents versus zotarolimus-eluting stents in all-comers requiring percutaneous coronary intervention (ReCre8): A multicenter randomized clinical trial.
Rozemeijer R, Stein M, Frambach P, Voskuil M, Kraaijeveld AO, Rodríguez-Olivares R, Timmers L, Pereira B, Rittersma SZ, Agostoni P, Doevendans PA, Stella PR. Rozemeijer R, et al. Among authors: stein m. Catheter Cardiovasc Interv. 2018 Feb 15;91(3):410-416. doi: 10.1002/ccd.27142. Epub 2017 May 22. Catheter Cardiovasc Interv. 2018. PMID: 28544782
Long-term follow-up of contemporary drug-eluting stent implantation in diabetic patients: Subanalysis of a randomized controlled trial.
van Hemert ND, Voskuil M, Rozemeijer R, Kraaijeveld AO, Rittersma SZ, Leenders GEH, Stein M, Frambach P, van der Harst P, Agostoni P, Stella PR; ReCre8 Study Investigators. van Hemert ND, et al. Among authors: stein m. Catheter Cardiovasc Interv. 2023 Feb;101(3):505-510. doi: 10.1002/ccd.30545. Epub 2023 Jan 18. Catheter Cardiovasc Interv. 2023. PMID: 36651339 Clinical Trial.
4,212 results